Pathogenetic substantiation of using selenium-containing drugs for the correct disorders of the blood plasma fibrinolytic system in patients with chronic diffuse liver diseases and euthyroid syndrome pathology

Abstract

The dynamics of the indices of fibrinolysis and cellular adhesion in patients with chronic diffuse liver diseases and euthyroid syndrome against the ground of administration of selenium-containing drugs, has been studied. The administration of selenium-containing drugs in a comprehensive therapy of patients with chronic diffuse liver diseases with disorders of thyroid homeostasis was found to improve the indices of the blood plasma fibrinolytic system, to reduce adhesive cellular properties and to increase total enzymatic activity of the blood plasma.

Authors and Affiliations

K. A. Chympoy, N. V. Pashkovska, V. I. Pankiv

Keywords

Related Articles

Role of Underweight and Overweight in the Development of Vertebral Pain Syndrome in Systemic Osteoporosis

A well-known risk factor for osteoporosis and fractures is weight, so its derivative — body mass index (BMI) — has been added to FRAX model. Numerous studies have shown a correlation between body mass index and risk of f...

Immune and anti-inflammatory factors in the mechanism of therapeutic effect of metformin in type 2 diabetes mellitus (analytical review including the results of own researches)

The review deals with the analysis of modern li­terature, including the results of own researches on the mecha­nism of the therapeutic effect of metformin in patients with type 2 diabetes mellitus (DM2) and its complicat...

Features of insulin resistance in patients with long history of type 1 diabetes mellitus, methods of Its correction

Background. A research aim is an estimation of insulin resistance (ІR), and also possibilities of its correction in patients with long-term experience of type 1 diabetes mellitus (DM). Materials and methods. 33 patients...

Download PDF file
  • EP ID EP222549
  • DOI -
  • Views 73
  • Downloads 0

How To Cite

K. A. Chympoy, N. V. Pashkovska, V. I. Pankiv (2015). Pathogenetic substantiation of using selenium-containing drugs for the correct disorders of the blood plasma fibrinolytic system in patients with chronic diffuse liver diseases and euthyroid syndrome pathology. Міжнародний ендокринологічний журнал, 3(67), 20-23. https://europub.co.uk/articles/-A-222549